Cargando…

Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization

In recent years, tissue engineering has achieved significant advancements towards the repair of damaged tissues. Until this day, the vascularization of engineered tissues remains a challenge to the development of large-scale artificial tissue. Recent breakthroughs in biomaterials and three-dimension...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, Peter Viktor, Chang, Hsiao-Min, Nishikawa, Masaki, Kimura, Hiroshi, Yanagawa, Norimoto, Hamon, Morgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615027/
https://www.ncbi.nlm.nih.gov/pubmed/34821744
http://dx.doi.org/10.3390/bioengineering8110178
_version_ 1784604005125586944
author Hauser, Peter Viktor
Chang, Hsiao-Min
Nishikawa, Masaki
Kimura, Hiroshi
Yanagawa, Norimoto
Hamon, Morgan
author_facet Hauser, Peter Viktor
Chang, Hsiao-Min
Nishikawa, Masaki
Kimura, Hiroshi
Yanagawa, Norimoto
Hamon, Morgan
author_sort Hauser, Peter Viktor
collection PubMed
description In recent years, tissue engineering has achieved significant advancements towards the repair of damaged tissues. Until this day, the vascularization of engineered tissues remains a challenge to the development of large-scale artificial tissue. Recent breakthroughs in biomaterials and three-dimensional (3D) printing have made it possible to manipulate two or more biomaterials with complementary mechanical and/or biological properties to create hybrid scaffolds that imitate natural tissues. Hydrogels have become essential biomaterials due to their tissue-like physical properties and their ability to include living cells and/or biological molecules. Furthermore, 3D printing, such as dispensing-based bioprinting, has progressed to the point where it can now be utilized to construct hybrid scaffolds with intricate structures. Current bioprinting approaches are still challenged by the need for the necessary biomimetic nano-resolution in combination with bioactive spatiotemporal signals. Moreover, the intricacies of multi-material bioprinting and hydrogel synthesis also pose a challenge to the construction of hybrid scaffolds. This manuscript presents a brief review of scaffold bioprinting to create vascularized tissues, covering the key features of vascular systems, scaffold-based bioprinting methods, and the materials and cell sources used. We will also present examples and discuss current limitations and potential future directions of the technology.
format Online
Article
Text
id pubmed-8615027
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86150272021-11-26 Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization Hauser, Peter Viktor Chang, Hsiao-Min Nishikawa, Masaki Kimura, Hiroshi Yanagawa, Norimoto Hamon, Morgan Bioengineering (Basel) Review In recent years, tissue engineering has achieved significant advancements towards the repair of damaged tissues. Until this day, the vascularization of engineered tissues remains a challenge to the development of large-scale artificial tissue. Recent breakthroughs in biomaterials and three-dimensional (3D) printing have made it possible to manipulate two or more biomaterials with complementary mechanical and/or biological properties to create hybrid scaffolds that imitate natural tissues. Hydrogels have become essential biomaterials due to their tissue-like physical properties and their ability to include living cells and/or biological molecules. Furthermore, 3D printing, such as dispensing-based bioprinting, has progressed to the point where it can now be utilized to construct hybrid scaffolds with intricate structures. Current bioprinting approaches are still challenged by the need for the necessary biomimetic nano-resolution in combination with bioactive spatiotemporal signals. Moreover, the intricacies of multi-material bioprinting and hydrogel synthesis also pose a challenge to the construction of hybrid scaffolds. This manuscript presents a brief review of scaffold bioprinting to create vascularized tissues, covering the key features of vascular systems, scaffold-based bioprinting methods, and the materials and cell sources used. We will also present examples and discuss current limitations and potential future directions of the technology. MDPI 2021-11-06 /pmc/articles/PMC8615027/ /pubmed/34821744 http://dx.doi.org/10.3390/bioengineering8110178 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hauser, Peter Viktor
Chang, Hsiao-Min
Nishikawa, Masaki
Kimura, Hiroshi
Yanagawa, Norimoto
Hamon, Morgan
Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization
title Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization
title_full Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization
title_fullStr Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization
title_full_unstemmed Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization
title_short Bioprinting Scaffolds for Vascular Tissues and Tissue Vascularization
title_sort bioprinting scaffolds for vascular tissues and tissue vascularization
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615027/
https://www.ncbi.nlm.nih.gov/pubmed/34821744
http://dx.doi.org/10.3390/bioengineering8110178
work_keys_str_mv AT hauserpeterviktor bioprintingscaffoldsforvasculartissuesandtissuevascularization
AT changhsiaomin bioprintingscaffoldsforvasculartissuesandtissuevascularization
AT nishikawamasaki bioprintingscaffoldsforvasculartissuesandtissuevascularization
AT kimurahiroshi bioprintingscaffoldsforvasculartissuesandtissuevascularization
AT yanagawanorimoto bioprintingscaffoldsforvasculartissuesandtissuevascularization
AT hamonmorgan bioprintingscaffoldsforvasculartissuesandtissuevascularization